sitryx-no-molecule-no-i-wb.png
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer
April 15, 2021 02:00 ET | Sitryx Therapeutics
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer Oxford, UK – 15 April 2021 – Sitryx (“the Company”), a biopharmaceutical company...
sitryx-no-molecule-no-i-wb.png
Sitryx appoints Pierre Legault as Chairman of its Board of Directors
March 24, 2021 03:00 ET | Sitryx Therapeutics
Sitryx appoints Pierre Legault as Chairman of its Board of Directors Oxford, UK – 24 March 2021 - Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop...
sitryx-no-molecule-no-i-wb.png
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism
October 08, 2018 07:00 ET | Sitryx Therapeutics
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism Fast-emerging area of research with potential to treat severe...
sitryx-no-molecule-no-i-wb.png
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism
October 08, 2018 02:00 ET | Sitryx Therapeutics
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism Fast-emerging area of research with potential to treat severe...